AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Feb 19, 2020
29821_dirs_2020-02-19_011c2d2e-f0ff-4521-a4fc-c9acc38218e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-18
Reporting Person: Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-18 | Deferred Stock Units | $ | A | 14824.0000 | Acquired | 2024-02-18 | Common Stock (14824.0000) | Direct |
| 2020-02-18 | Stock Option (Right to Buy) | $42.1600 | A | 55309.0000 | Acquired | 2030-02-18 | Common Stock (55309.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.